Sun Pharma remains on track to expand its innovative medicine portfolio through enhanced marketing efforts on new launches, increasing the prescriber base the prescription rate for existing products, adds the brokerage.
Sun Pharma remains on track to expand its innovative medicine portfolio through enhanced marketing efforts on new launches, increasing the prescriber base the prescription rate for existing products, adds the brokerage.
<iframe src="https://hindustansphere.com/embed/cluster/9ecf6607266b7acccc8574235f45f499e298bab2" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sun Pharma Shares In Focus As Motilal Oswal Remains Bullish After Q1 Results — Check Hiked Target Price"></iframe>
